117 related articles for article (PubMed ID: 27885995)
1. Transdermal delivery of estradiol-loaded PLGA nanoparticles using iontophoresis for treatment of osteoporosis.
Takeuchi I; Fukuda K; Kobayashi S; Makino K
Biomed Mater Eng; 2016 Nov; 27(5):475-483. PubMed ID: 27885995
[TBL] [Abstract][Full Text] [Related]
2. Estradiol-loaded PLGA nanoparticles for improving low bone mineral density of cancellous bone caused by osteoporosis: Application of enhanced charged nanoparticles with iontophoresis.
Takeuchi I; Kobayashi S; Hida Y; Makino K
Colloids Surf B Biointerfaces; 2017 Jul; 155():35-40. PubMed ID: 28391082
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis.
Tomoda K; Watanabe A; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Sep; 97():84-9. PubMed ID: 22609586
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):706-10. PubMed ID: 21885261
[TBL] [Abstract][Full Text] [Related]
6. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
Takeuchi I; Takeshita T; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
[TBL] [Abstract][Full Text] [Related]
7. Skin permeability and transdermal delivery route of 50-nm indomethacin-loaded PLGA nanoparticles.
Takeuchi I; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():312-317. PubMed ID: 28858661
[TBL] [Abstract][Full Text] [Related]
8. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.
Mittal G; Carswell H; Brett R; Currie S; Kumar MN
J Control Release; 2011 Mar; 150(2):220-8. PubMed ID: 21111014
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis.
Fazil M; Hassan MQ; Baboota S; Ali J
Drug Deliv; 2016 Sep; 23(7):2428-2438. PubMed ID: 25625496
[TBL] [Abstract][Full Text] [Related]
13. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle delivery for transdermal HRT.
Valenzuela P; Simon JA
Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
[TBL] [Abstract][Full Text] [Related]
15. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
Sahana DK; Mittal G; Bhardwaj V; Kumar MN
J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
[TBL] [Abstract][Full Text] [Related]
16. In vivo calcium and phosphate iontophoresis for the topical treatment of osteoporosis.
Gomez I; Szabó A; Pap L; Pap L; Boda K; Szekanecz Z
Phys Ther; 2012 Feb; 92(2):289-97. PubMed ID: 22052949
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
18. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
19. The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system.
Zakeri-Milani P; Loveymi BD; Jelvehgari M; Valizadeh H
Colloids Surf B Biointerfaces; 2013 Mar; 103():174-81. PubMed ID: 23201735
[TBL] [Abstract][Full Text] [Related]
20. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]